|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diffuse Large B Cell Lymphoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Lymphoma | |||||
| Lymphoma, B-Cell | |||||
| Lymphoma, Large B-Cell, Diffuse | |||||
| 3 | More general conditions related to this trial | ||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lymphatic Diseases | |||||
| Lymphoma, Non-Hodgkin | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 4 | Interventions listed in this trial | ||||
| diffusion MRI | |||||
| 5 | Sponsors listed in this trial | ||||
| University of Michigan Cancer Center | |||||